Why Does Mounjaro Make You Have Diarrhoea — and What Can You Do About It?

What's actually happening in your gut when Mounjaro is on board

Tirzepatide activates two receptors involved in appetite and blood-sugar regulation: GIP and GLP-1. One consequence of GLP-1 activation is a significant slowing of gastric emptying, food sits in your stomach longer before passing into the small intestine. That sounds settled, but the downstream effect on bowel motility is less predictable. Some people experience constipation; others find the opposite, with looser and more frequent stools. The NHS tirzepatide patient information page lists diarrhoea alongside nausea and vomiting as very common reactions, meaning they affect more than one in ten people taking the medicine.

The pattern matters. Diarrhoea tends to be most pronounced when you start at 2.5mg and again each time your dose steps up. If you want to understand why Mounjaro causes diarrhoea at a biological level, the short answer is that your gut is adapting to a new hormonal environment, and that process takes time. Keeping a glass of water by the kettle each morning is a simple reminder to stay hydrated on days when your stomach is unsettled, dehydration can creep up faster than people expect.

For a fuller look at how the gut adjusts, including burping and nausea alongside looser stools, the complete Mounjaro side-effects guide covers the wider picture.

The decision about carrying on: factors worth weighing

If you're asking why Mounjaro makes you have diarrhoea, you're probably also deciding whether to push through, flag it, or do something differently. That's a reasonable thing to think through carefully rather than react to in the moment.

Most people tolerate the GI effects with practical adjustments: smaller meals, lower-fat food choices, good hydration, and giving the body time to adjust. The practical steps for managing diarrhoea on Mounjaro go into this in more detail. What tends not to help is rushing up the dose ladder, your prescriber controls titration timing precisely because moving too fast significantly amplifies GI side effects. If your bowel symptoms are making treatment feel unmanageable, that is a conversation to have with your prescriber before you make any decision about stopping or pausing, not after.

It is also worth knowing that the experience varies considerably between individuals. Some people have essentially no GI disruption; others find week two harder than week one. Hormonal factors and pre-existing gut conditions can influence how pronounced symptoms are. Your prescriber builds that picture during assessment, it is one of the reasons a clinical review happens before every repeat, not just at the start.

Curious about other GI effects alongside diarrhoea? The reason Mounjaro causes burping comes down to the same gastric-emptying mechanism, and understanding the connection often helps.

When to get medical help, and what counts as urgent

Diarrhoea during Mounjaro treatment is expected and usually mild. It becomes a medical matter when it is severe, persisting beyond a week or two without improvement, or accompanied by signs of dehydration: dark urine, dizziness, a dry mouth, or feeling faint. If you cannot keep fluids down, contact your GP or call 111.

There is a more serious scenario to be aware of. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines highlighting acute pancreatitis as an infrequent but potentially serious side effect. The symptom to act on is severe, persistent stomach pain that radiates through to your back, with or without vomiting. That is different from ordinary loose stools after a dose increase, but it matters that you know the distinction. If that kind of pain develops, stop treatment and seek urgent medical attention.

Suspected side effects, including unusual bowel symptoms, can be reported to the MHRA through the Yellow Card scheme. Patient reports genuinely contribute to ongoing safety monitoring of newer medicines like tirzepatide, which carries a Black Triangle (▼) designation while post-marketing evidence is collected.

If you have ongoing concerns, our support team is available seven days a week and your prescriber can be reached through the aftercare pathway.

How the consultation at nume approaches this

Side-effect risk is part of every clinical assessment, not a footnote. A GPhC-registered Independent Prescriber reads your consultation responses personally, considers your health history, and discusses whether treatment is suitable before anything is approved. That conversation includes the likely GI profile of tirzepatide, so if you are nervous about diarrhoea before you start, or managing it now and wondering whether to continue, that is exactly the kind of detail the prescriber is there to weigh up with you.

If you're considering treatment for the first time, the treatment overview page outlines both Mounjaro and Wegovy in plain terms, so you can read about the differences before speaking to a prescriber. The consultation is free. Check your eligibility and our prescribers will take it from there.